GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a significant focus in medical investigation, largely due to its notable impact on treating ailments such as type 2 diabetes and weight gain. New studies have shown that beyond glucose regulation, GLP-1 drugs offer benefits for cardiovascular function and possibly